A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

July 6, 2021

Study Completion Date

November 24, 2021

Conditions
Early Breast Cancer
Interventions
DRUG

Giredestrant

During the window-of-opportunity phase (first 2 weeks) giredestrant will be taken orally once per day (QD) as a single agent. During the neoadjuvant treatment phase, giredestrant will be taken orally QD on Days 1-28 of each 28-day cycle for a total of 4 cycles, in combination with palbociclib.

DRUG

Anastrozole

During the window-of-opportunity phase (first 2 weeks), anastrozole 1 mg will be taken orally QD as a single agent. During the neoadjuvant treatment phase, anastrozole 1 mg will be taken orally QD on Days 1-28 of each 28-day cycle for a total of 4 cycles, in combination with palbociclib.

DRUG

Palbociclib

During the neoadjuvant treatment phase, palbociclib 125 mg will be taken orally QD on Days 1-21 of a 28-day cycle for a total of 4 cycles.

PROCEDURE

Surgery

Surgery must be performed within a maximum of 14 days after the final cycle in the neoadjuvant treatment phase and ideally should occur as soon as possible after the last dose of study treatment.

Trial Locations (65)

100

National Taiwan Uni Hospital; General Surgery, Taipei

704

National Cheng Kung Uni Hospital; Surgery, Tainan City

2109

Macquarie University Hospital, Macquarie Park

2145

Westmead Hospital; Medical Oncology and Pallative Care, Westmead

6000

Bacs-Kiskun Megyei Korhaz, SZTE AOK Oktato Korhaza, Onkoradiologiai Kozpont; Onkoradiologiai Kozpont, Kecskemét

6591

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

7100

Tolna Megyei Kórház, Onkológia, Szekszárd

11407

Hospital de Jerez de la Frontera; Servicio de Oncologia, Jerez de la Frontera

18014

Hospital Universitario Virgen de las Nieves : Hospital General, Granada

18016

Hospital Clinico San Cecilio, Granada

25198

Hospital Universitari Arnau de Vilanova, Lleida

27003

Hospital Universitario Lucus Augusti, Lugo

28040

Fundación Jimenez Díaz, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

28922

Hosp Univ Fundacion Alcorcon, Madrid

29009

Khmelnytsky Regional Antitumor Center; Department of Breast, Skin, Soft Tissues and Bones Tumors, Khmelnytskyi

30120

Hospital Universitario Virgen de La Arrixaca, Murcia

31008

Hospital de Navarra; Servicio de Oncologia, Navarra

32806

Orlando Health Inc., Orlando

33401

SCRI Florida Cancer Specialists East, West Palm Beach

37203

Tennessee Oncology; Sarah Cannon Research Institute, Nashville

38320

Hospital Universitario de Canarias;servicio de Oncologia, San Cristóbal de La Laguna

40235

LUISENKRANKENHAUS; Senological Oncology, Düsseldorf

41009

Hospital Universitario Virgen Macarena, Seville

43204

Hospital Universitari Sant Joan de Reus; Planta baja, color lila, Reus

46014

Hospital General Universitario de Valencia, Valencia

49102

Municipal institution Dnipropetrovsk City Multifield Clinical Hospital #4; dept. of Chemotherapy, Dnipropetrovsk

50048

ME Kryviy Rih Oncology Dispensary of Dnipropetrovs'k Regional Council; Chemotherapy Department, Kryvyi Rih

53762

Univ of Wisconsin-Madison; Clinical Science Center, Madison

61070

Regional Oncology Center of Kharkiv Regional Council; Department of Soft Tissues and Breast Cancer, Kharkiv

65025

Odesa Regional Clinical Hospital; Department of Thoracic Surgery, Odesa

90404

UCLA Hematology Oncology-Santa Monica, Santa Monica

90505

Torrance Memorial Physician Network/Cancer Care, Torrance

91054

UNIVERSITATSKLINIKUM ERLANGEN; Department of Gynecology and Obstetrics, Erlangen

91505

UCLA - Burbank, Burbank

92653

UCLA - Laguna Hills, Laguna Hills

93401

UCLA Hematology/Oncology-San Luis Obispo, San Luis Obispo

143423

Moscow City Oncology Hospital #62, Moscovskaya Oblast

195271

Private Healthcare Institution Clinical Hospital RZhD Medicine, Saint Petersburg

197758

"FSI SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy", Saint Petersburg

S-Pb clinical scientific practical center of specialized kinds of medical care (oncological), Saint Petersburg

280146

Hospital Universitario La Paz, Madrid

420029

Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan'

603081

Filial #1 Regional Oncology Dispensary of Nizhniy Novgorod, Nizhny Novgorod

07039

Saint Barnabas Medical Center Cancer Center, Livingston

50040-000

Hospital do Cancer de Pernambuco - HCP, Recife

90050-170

Santa Casa de Misericordia de Porto Alegre, Porto Alegre

01317-001

Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo

04014-002

Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA, São Paulo

01307

Universitätsklinikum Dresden, Dresden

81-519

Szpital Morski Im. Pck; Oncology & Radiotherapy Dept, Gdynia

20-090

COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej, Lublin

02-781

Centrum Onkologii - Inst.Im. Marii Sklodowskiej-Curie; Oncology, Warsaw

53-413

DOLNOSLASKIE CENTRUM ONKOLOGII; Oddzial Chirurgii Piersi, Wroclaw

410-769

National Cancer Center; Medical Oncology, Gyeonggi-do

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

110-744

Severance Hospital; Internal Medicine, Seoul

135-710

Samsung Medical Center, Seoul

08916

Institutio Catalan De Oncologia, Badalona

08243

Complejo Hospitalario de Althaia; Servicio de Oncologia, Manresa

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

08028

Hospital Universitario Quirón Dexeus, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

04107

Kyiv Regional Oncological Dispensary, Kyiv

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT04436744 - A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) | Biotech Hunter | Biotech Hunter